Can Fite Biopharma Ltd (NYSE American:CANF)
| 2.51 Delayed Data As of May 22 |  +0.34 / +15.67%Today’s Change | 1.08 Today|||52-Week Range 4.95 | -23.94% Year-to-Date |
Latest CANF News | Press Releases
No recent news for Can Fite Biopharma Ltd.
Today’s Trading
| Previous close | 2.17 |
| Today’s open | 2.21 |
| Day’s range | 2.18 - 2.58 |
| Volume | 1,486,943 |
| Average volume (3 months) | 1,005,597 |
| Market cap | $23.1M |
Data as of 3:59pm ET, 05/22/2020
Growth & Valuation
| Earnings growth (last year) | +33.51% |
| Earnings growth (this year) | +63.64% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -46.46% |
| P/E ratio | NM |
| Price/Sales | 4.64 |
| Price/Book | 11.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCGNOcugen Inc | -0.01 | -2.73% |
| VTGNVistaGen Therapeutic... | -0.00 | -1.05% |
| IGCIndia Globalization ... | +0.01 | +1.96% |
| ---- |
Data as of 4:20pm ET, 05/22/2020
Financials
| Next reporting date | May 28, 2020 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $2.0M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -471.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Petach Tikva, Tel Aviv |
Forecasts
